Paul A. Wender

Founder at Bryologyx, Inc.

Health Technology

Network origin in Paul A. Wender first degree

Entity	Entity type	Industry
Bryologyx, Inc. Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. 7	Holding Company	Pharmaceuticals: Major	7

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Paul A. Wender via their personal network

Company	Sector	Related people	Main position
ABAXIS INC	Medical Specialties	Clinton H. Severson	Chief Executive Officer
TRINITY BIOTECH PLC	Medical Specialties	Clinton H. Severson	Director/Board Member
Northlea Partners LLLP		John H. Abeles	Corporate Officer/Principal
LXN Corp LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million.	Pharmaceuticals: Major	Clinton H. Severson	Director/Board Member
CUTERA, INC.	Medical Specialties	Clinton H. Severson	Director/Board Member
RESPONSE BIOMEDICAL CORP	Miscellaneous Commercial Services	Clinton H. Severson	Director/Board Member
ChemBridge Corp. ChemBridge Corp. BiotechnologyHealth Technology ChemBridge Corp. is a private company that engages in the research, development, and production of chemical products. The company is based in San Diego, CA. The company was founded by Nelson L. Levy.	Biotechnology	Nelson L. Levy	Founder
University of Notre Dame	College/University	Thomas M. Loarie	Undergraduate Degree
NEUROTROPE, INC.	Pharmaceuticals: Major	John H. Abeles	Chairman
Duke University Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.	College/University	Nelson L. Levy	Doctorate Degree
MAST Immunosystems, Inc. MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Part of Resonac Holdings Corp., MAST Immunosystems, Inc. is a company that develops innovative medical diagnostics and equipment. The company is based in Mountain View, CA. MAST Immunosystems was acquired by Resonac Corp., part of Resonac Holdings Corp. from 2020-04-20 on 1996-11-04 for $40.0 million.	Medical Specialties	Clinton H. Severson	President
Novacor, Inc. Novacor, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Medtronic Plc, Novacor, Inc. is an American company that develops artificial heart and related technologies. The company is based in CA. Novacor was acquired by World Heart Corp., a subsidiary of Medtronic Plc from Edwards Lifesciences Corp. on June 30, 2000 for $58 million.	Miscellaneous Commercial Services	Thomas M. Loarie	Chief Operating Officer
Yale University	College/University	Nelson L. Levy	Undergraduate Degree
Minot State University	College/University	Clinton H. Severson	Undergraduate Degree
University of Birmingham	College/University	John H. Abeles	Doctorate Degree
Mercator MedSystems, Inc. Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA.	Medical Specialties	Thomas M. Loarie	Chief Executive Officer
zuChem, Inc. zuChem, Inc. Wholesale DistributorsDistribution Services zuChem, Inc. manufactures and supplies glycochemicals for the pharmaceutical, food and related industries. Its products include natural polyols, rare sugars and carbohydrates. Its glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients. The company was founded by David C. Demirjian in 2001 and is headquartered in Chicago, IL.	Wholesale Distributors	Nelson L. Levy	Director/Board Member
Advanced Medical Technology Association Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.	Miscellaneous Commercial Services	Thomas M. Loarie	Corporate Officer/Principal
CoreTechs Corp.		Nelson L. Levy	Chief Executive Officer
Combimatrix Molecular Diagnostics, Inc.		John H. Abeles	Director/Board Member
International University of Health Sciences	College/University	John H. Abeles	Corporate Officer/Principal
UniMedica, Inc.		John H. Abeles	Chairman
CONTRAFECT CORPORATION	Biotechnology	John H. Abeles	Founder
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Biotechnology	John H. Abeles	Director/Board Member
Baystar Biosciences		John H. Abeles	Director/Board Member
Medezrin Ltd.		John H. Abeles	Director/Board Member
Medisync Midwest LLC Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH.	Miscellaneous Commercial Services	John H. Abeles	Director/Board Member
Higuchi Bioscience Center		John H. Abeles	Director/Board Member
CardioProfile, Inc.		Thomas M. Loarie	Founder
American Heyer-Schulte		Thomas M. Loarie	President
International Opera Alliance International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA.	Miscellaneous Commercial Services	John H. Abeles	Director/Board Member
Players Club		John H. Abeles	Corporate Officer/Principal
OHK Medical Devices, Inc. OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI.	Medical Specialties	John H. Abeles	Director/Board Member
Dalyda Finance LLC		John H. Abeles	Corporate Officer/Principal
MEDITE CANCER DIAGNOSTICS INC	Medical Specialties	John H. Abeles	Director/Board Member
Hadean Ventures AS Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway.	Investment Managers	John H. Abeles	Private Equity Investor
Pattern Pharma, Inc. Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada.	Pharmaceuticals: Major	John H. Abeles	Director/Board Member
Vagelos College of Physicians & Surgeons	College/University	Nelson L. Levy	Doctorate Degree
Oncolyze, Inc. Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.	Biotechnology	John H. Abeles	Founder